[Federal Register Volume 76, Number 250 (Thursday, December 29, 2011)]
[Notices]
[Pages 81947-81948]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2011-33396]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


World Trade Center Health Program Scientific/Technical Advisory 
Committee (WTCHP STAC or Advisory Committee), National Institute for 
Occupational Safety and Health (NIOSH)

    In accordance with section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463) the Centers for Disease Control and 
Prevention (CDC), announces the following meetings of the 
aforementioned committee:

Committee Public Meeting Times and Dates:  (All times are Eastern 
Standard Time).

Teleconference Meeting:  1 p.m.-5 p.m., January 24, 2012.
    This meeting is available via the USA toll-free, dial-in number: 1-
(888) 801-1939. To be automatically connected to the meeting, you will 
need to enter the following participant code: 62062756.

Public Comment Times and Date:  4 p.m.-4:45 p.m., January 24, 2012.
    Please note that the public comment period ends at the time 
indicated or following the last call for comments, whichever is 
earlier. Members of the public who want to comment must sign up by 
providing their name by mail, facsimile, email, or telephone, as given 
below. Each commenter will be provided up to five minutes for comment. 
A limited number of time slots are available and will be assigned on a 
first come-first served basis. Written comments will also be accepted 
from those unable to attend the public session.
    Status: Open to the public, limited only by the number of telephone 
lines. The conference line will accommodate up to 100 callers; 
therefore it is suggested that those interested in calling in to listen 
to the committee meeting share a line when possible.
    Background: The Advisory Committee was established by Public Law 
111-347 (The James Zadroga 9/11 Health and Compensation Act of 2010, 
Title XXXIII of the Public Health Service Act), enacted on January 2, 
2011 and codified at 42 U.S.C. 300mm-300mm-61.
    Purpose: The purpose of the Advisory Committee is to review 
scientific and medical evidence and to make recommendations to the 
World Trade Center (WTC) Program Administrator regarding additional WTC 
Health Program eligibility criteria and potential additions to the list 
of covered WTC-related health conditions. Title XXXIII of the Public 
Health Service Act established within the Department of Health and 
Human Services (HHS), the World Trade Center (WTC) Health Program, to 
be administered by the WTC Program Administrator. The WTC Health 
Program provides: (1) Medical monitoring and treatment benefits to 
eligible emergency responders and recovery and cleanup workers 
(including those who are Federal employees) who responded to the 
September 11, 2011, terrorist attacks, and (2) initial health 
evaluation, monitoring, and treatment benefits to residents and other 
building occupants and area workers in New York City who were directly 
impacted and adversely affected by such attacks (``survivors''). 
Certain specific activities of the WTC Program Administrator are 
reserved to the Secretary, HHS, to delegate at her discretion; other 
WTC Program Administrator duties not explicitly reserved to the 
Secretary, HHS, are assigned to the Director, NIOSH. The administration 
of the Advisory Committee established under Section 300mm-1(a) is left 
to the Director of NIOSH in his role as WTC Program Administrator. CDC 
and NIOSH provide funding, staffing, and administrative support 
services for the Advisory Committee. The charter was issued on May 12, 
2011, and will expire on May 12, 2013.

Matters To Be Discussed: The agenda for the Advisory Committee meeting 
includes: WTC Health Program Research Priorities and the petition to 
add cancer to the list of WTC Health Program covered conditions. The 
agenda is subject to change as priorities dictate. In the event an 
individual cannot attend, written comments may be submitted. The 
comments should be limited to two pages and submitted to the contact 
person below by January 18, 2012. Efforts will be made to provide the 
two-page written comments received by the deadline below to the 
committee members before the meeting. Comments in excess of two pages 
will be made publicly available at the NIOSH docket (http://www.cdc.gov/niosh/docket/archive/docket248.html).

Public Comment Sign-Up and Submissions to the Docket: To sign up to 
provide public comments or to submit comments to the docket, send 
information to the NIOSH Docket Office by one of the following means:
    Mail: NIOSH Docket Office, Robert A. Taft Laboratories, MS-C-34, 
4676 Columbia Parkway, Cincinnati, Ohio 45226.
    Facsimile: (513) 533-8285.
    Email: [email protected].
    Telephone: (513) 533-8611.
    Submissions to the docket should reference docket 248.
    Policy on Redaction of Committee Meeting Transcripts (Public 
Comment): Transcripts will be prepared and posted to NIOSH Docket 248 
within 60 days after the meeting. If a person making a comment gives 
his or her name, no attempt will be made to redact that name. NIOSH 
will take reasonable steps to ensure that individuals making public 
comments are aware of the fact that their comments (including their 
name, if provided) will appear in a transcript of the meeting posted on 
a public Web site. Such reasonable steps include: (a) A statement read 
at the start of the meeting stating that transcripts will be posted and 
names of speakers will not be redacted; and (b) A printed copy of the 
statement mentioned in (a) above will be displayed on the table where 
individuals sign up to make public comments. If individuals in making a 
statement reveal personal information (e.g., medical information) about 
themselves, that information will not usually be redacted. The CDC 
Freedom of Information Act coordinator will, however, review such 
revelations in accordance with the Freedom of Information Act and if 
deemed appropriate, will redact such information. Disclosures of 
information concerning third party medical information will be 
redacted.

Contact Person for More Information: Paul J. Middendorf, Ph.D., 
Designated Federal Official, NIOSH, CDC, 4676 Columbia Parkway, 
MailStop R-45, Cincinnati, Ohio 45226, Telephone: 1 (888) 982-4748; 
email: [email protected].
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register Notices pertaining to 
announcements of meetings and other committee management activities, 
for both the

[[Page 81948]]

Centers for Disease Control and Prevention, and the Agency for Toxic 
Substances and Disease Registry.

    Dated: December 22, 2011.
Ronald Ergle,
Acting Director, Management Analysis and Services Office Centers for 
Disease Control and Prevention.
[FR Doc. 2011-33396 Filed 12-28-11; 8:45 am]
BILLING CODE 4163-18-P